PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-22.17%
Negative R&D growth (spending reduction) needs careful analysis. Benjamin Graham would examine impact on competitive position.
-22.47%
Negative G&A growth (overhead reduction) needs verification. Benjamin Graham would examine impact on operations.
No Data
No Data available this quarter, please select a different quarter.
-12.79%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
-22.23%
Negative operating expenses growth needs verification. Benjamin Graham would examine sustainability.
-22.23%
Negative total costs growth needs verification. Benjamin Graham would examine sustainability.
10981.63%
Interest expense growth above 10% signals concerning debt expansion. Seth Klarman would demand justification.
-12.79%
Negative D&A growth needs verification. Benjamin Graham would examine asset reduction strategy.
22.24%
EBITDA growth above 15% demonstrates exceptional operating performance. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
22.23%
Operating income growth above 15% demonstrates exceptional core profitability. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-88.23%
Negative other expenses growth needs verification. Benjamin Graham would examine sustainability.
18.34%
Pre-tax income growth above 15% demonstrates exceptional profitability improvement. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
88.23%
Tax expense growth above 20% signals concerning expansion. Seth Klarman would scrutinize tax strategy.
18.34%
Net income growth above 15% demonstrates exceptional bottom-line expansion. Warren Buffett would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
32.95%
EPS growth above 15% demonstrates exceptional shareholder value creation. Warren Buffett would verify sustainability.
32.95%
Diluted EPS growth above 15% demonstrates exceptional value creation despite potential dilution. Warren Buffett would verify sustainability.
21.91%
Share increase above 2% signals significant dilution. Seth Klarman would demand explanation.
21.91%
Diluted share increase above 2% signals significant dilution. Seth Klarman would demand explanation.